Elevated plasma N-terminal pro-brain natriuretic peptide levels in acute ischemic stroke

American Heart Journal

Volumn 151, Issue 5, 2006, Pages 1115-1122

  Iltumur, Kenan ^a   Karabulut, Aziz ^a   Apak, Ismail ^a   Aluclu, Ufuk ^a   Ariturk, Zuhal ^a   Toprak, Nizamettin ^a  

^a DICLE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; CREATINE KINASE MB; NEUROHORMONE; TROPONIN I; UNCLASSIFIED DRUG;

ACUTE DISEASE; ADULT; AGED; ARTICLE; BLOOD CHEMISTRY; BRAIN DAMAGE; BRAIN INFARCTION SIZE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CEREBROVASCULAR ACCIDENT; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC IMAGING; DISEASE MARKER; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HEART RATE; HUMAN; INSULA; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC EXAMINATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION;

EID: 33646110735     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2005.05.022     Document Type: Article

References (38)

1. Oppenheimer S., and Norris J.W. Cardiac manifestations of acute neurological lesions. In: Aminoff M.J. (Ed). Neurology and general medicine: the neurological aspects of medical disorder. 2nd ed. (1995), Churchill-Livingstone, New York (NY) 183-200
2. Ay H., Arsava E.M., and Saribas O. Creatine kinase-MB elevation after stroke is not cardiac in origin: comparison with troponin T levels. Stroke 33 (2002) 286-289
3. Sen S., and Oppenheimer S.M. Cardiac disorders and stroke. Curr Opin Neurol 11 (1998) 51-56
4. Kolin A., and Norris J.W. Myocardial damage from acute cerebral lesions. Stroke 15 (1984) 990-993
5. Cechetto D.F., Wilson J.X., Smith K.E., et al. Autonomic and myocardial changes in middle cerebral artery occlusion: stroke models in the rat. Brain Res 502 (1989) 296-305
6. Tokgozoglu S.L., Batur M.K., Topcuoglu M.A., et al. Effects of stroke localization on cardiac autonomic balance and sudden death. Stroke 30 (1999) 1307-1311
7. Parekh N., Venkatesh B., Cross D., et al. Cardiac troponin I predicts myocardial dysfunction in aneurysmal subarachnoid hemorrhage. J Am Coll Cardiol 36 (2000) 1328-1335
8. Fonarow G.C., and Horwich T.B. Combining natriuretic peptides and necrosis markers in determining prognosis in heart failure. Rev Cardiovasc Med 4 Suppl. 4 (2003) 20-28
9. McCullough P.A., Omland T., and Maisel A.S. B-type natriuretic peptides: a diagnostic breakthrough for clinicians. Rev Cardiovasc Med 4 (2003) 72-80
10. Daly C., Fox K., and Henein M. Natriuretic peptides in the diagnosis of heart disease-first amongst equals?. Int J Cardiol 84 (2002) 107-113
11. Maisel A. B-type natriuretic peptide levels: diagnostic and prognostic in congestive heart failure: what's next?. Circulation 105 (2002) 2328-2331
12. Kruger S., Graf J., Merx M.W., et al. Brain natriuretic peptide predicts right heart failure in patients with acute pulmonary embolism. Am Heart J 147 (2004) 60-65
13. Bando M., Ishii Y., Sugiyama Y., et al. Elevated plasma brain natriuretic peptide levels in chronic respiratory failure with cor pulmonale. Respir Med 93 (1999) 507-514
14. Buckley M.G., Sethi D., Markandu N.D., et al. Plasma concentrations and comparisons of brain natriuretic peptide and atrial natriuretic peptide in normal subjects, cardiac transplant recipients and patients with dialysis-independent or dialysis dependent chronic renal failure. Clin Sci 83 (1992) 437-444
15. Sagnella G.A. Measurement and significance of circulating natriuretic peptides in cardiovascular disease. Clin Sci 95 (1998) 519-529
16. Remme W.J., and Swedberg K. Task Force for the Diagnosis and Treatment of Chronic Heart Failure, European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 22 (2001) 1527-1560
17. Tomida M., Muraki M., Uemura K., et al. Plasma concentrations of brain natriuretic peptide in patients with subarachnoid hemorrhage. Stroke 29 (1998) 1584-1587
18. Schiller N.B., Shah P.M., Crawford M., et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, subcommittee on quantitation of two-dimensional echocardiograms. J Am Soc Echocardiogr 2 (1989) 358-367
19. Yu H.C., and Sanderson J.E. Different prognostic significance of right and left ventricular diastolic dysfunction in heart failure. Clin Cardiol 22 (1999) 504-512
20. Myers M.G., Norris J.W., Hachniski V.C., et al. Plasma norepinephrine in stroke. Stroke 12 (1981) 200-204
21. Cruickschank J.M., Neil-Dwyer G., Hayes Y., et al. Stress/catecholamine-induced cardiac necrosis. Reduction by beta 1-selective blockade. Postgrad Med 29 (1988) 140-147
22. Masuda T., Sato K., Yamamoto S., et al. Sympathetic nervous activity and myocardial damage immediately after subarachnoid hemorrhage in a unique animal model. Stroke 33 (2002) 1671-1676
23. Mann D.L., Kent R.L., Parsons B., et al. Adrenergic effects on the biology of the adult mammalian cardiocyte. Circulation 85 (1992) 790-804
24. Fung J.W., Yu C., Yip G., et al. Effect of beta blockade (carvedilol or metoprolol) on activation of the renin-angiotensin-aldosterone system and natriuretic peptides in chronic heart failure. Am J Cardiol 92 (2003) 406-410
25. de Lemos J.A., Morrow D.A., Bentley J.H., et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 345 (2001) 1014-1021
26. Packer M. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol 20 (1992) 248-254
27. de Lemos J.A., and Morrow D.A. Brain natriuretic peptide measurement in acute coronary syndromes: ready for clinical application?. Circulation 106 (2002) 2868-2870
28. Kikuta K., Yasue H., Yoshimura M., et al. Increased plasma levels of B-type natriuretic peptide in patients with unstable angina. Am Heart J 131 (1996) 101-107
29. Hertzer N.R., Young J.R., Beven E.G., et al. Coronary angiography in 506 patients with extracranial cerebrovascular disease. Arch Intern Med 145 (1985) 849-852
30. Selvais P.L., Donckier J.E., Robert A., et al. Cardiac natriuretic peptides for diagnosis and risk stratification in heart failure: influences of left ventricular dysfunction and coronary artery disease on cardiac hormonal activation. Eur J Clin Invest 28 (1998) 636-642
31. Dawson S.L., Evans S.N., Manktelow B.N., et al. Diurnal blood pressure change varies with stroke subtype in the acute phase. Stroke 29 (1998) 1519-1524
32. Dimant J., and Grob D. Electrocardiographic changes and myocardial damage in patients with acute cerebrovascular accidents. Stroke 8 (1977) 448-455
33. Dogan A., Tunc E., Ozturk M., et al. Comparison of electrocardiographic abnormalities in patients with ischemic and hemorrhagic stroke. Anadolu Kardiyol Derg 4 (2004) 135-140
34. Khechinashvili G., and Asplund K. Electrocardiographic changes in patients with acute stroke: a systematic review. Cerebrovasc Dis 14 (2002) 67-76
35. Lynch J.R., Blessing R., White W.D., et al. Novel diagnostic test for acute stroke. Stroke 35 (2004) 57-63
36. Holmer S.R., Hengstenberg C., Mayer B., et al. Marked suppression of renin levels by beta receptor blocker in patients treated with standard heart failure therapy: a potential mechanism of benefit from beta-blockade. J Intern Med 249 (2001) 167-172
37. Neil-Dwyer G., Walter P., Cruikshank J.M., et al. Effect of propranolol and phentolamine on myocardial necrosis after subarachnoid haemorrhage. BMJ 2 (1978) 990-992
38. Rolak L.A., and Rokey R. The patient with concomitant stroke and myocardial infarction: clinical features. In: Rolak L.A., and Rokey R. (Eds). Coronary and cerebral vascular disease: a practical guide (1990), Futura, New York (NY) 117-137